Mereo BioPharma Group PLC ADR Earnings

The next earnings date for Mereo BioPharma Group PLC ADR is November 18, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Mereo BioPharma Group PLC ADR Earnings

Report Date	Estimated Earnings Per Share
11/18/2025	$0.01

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Mereo BioPharma Group PLC ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/12/2025	---	$-0.01	-65.56%
05/23/2025	Before Market	$-0.02	-37.27%
11/12/2024	---	$-0.10	---
09/05/2024	Before Market	$-0.09	-762.00%
05/15/2024	After Market	$-0.06	---
11/17/2023	After Market	$0	---
09/07/2023	Before Market	$-0.02	0.00%
05/31/2023	---	$0	---
03/28/2023	After Market	$-0.02	---
08/11/2021	---	$0	100.00%
06/02/2021	---	$-0.14	0.00%
03/31/2021	After Market	$0.08	---
12/31/2020	---	$-0.24	---
09/29/2020	Before Market	$-0.23	---
06/15/2020	After Market	$-3.28	-1,160.38%
03/31/2020	---	$-3.29	---
12/31/2019	---	$-0.59	---
09/17/2019	Before Market	$-0.54	---
04/29/2019	Before Market	$-0.70	---
03/31/2019	---	$-0.72	---
12/31/2018	---	$-0.67	---
09/30/2018	---	$-0.69	---
06/30/2018	---	$-0.79	---
03/31/2018	---	$-0.84	---
12/31/2017	---	$-0.77	---
09/30/2017	---	$-0.76	---
06/30/2017	---	$-1.10	---
03/31/2017	---	$-1.06	---
12/31/2016	---	$-0.65	---
09/30/2016	---	$-0.68	---
06/30/2016	---	$-1.96	---
03/31/2016	---	$-2.13	---

More About Mereo BioPharma Group PLC ADR

Website

https://www.mereobiopharma.com

Country

USA

Full Time Employees

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.

“Mereo BioPharma Group PLC ADR Earnings” Can Refer to the Mereo BioPharma Group PLC ADR Earnings Date

Some people say “Mereo BioPharma Group PLC ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Mereo BioPharma Group PLC ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Mereo BioPharma Group PLC ADR Stock on the Earnings Date

If you own Mereo BioPharma Group PLC ADR stock (MREO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Mereo BioPharma Group PLC ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Mereo BioPharma Group PLC ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Mereo BioPharma Group PLC ADR Earnings

You can contact us any time if you would like to ask questions about Mereo BioPharma Group PLC ADR earnings or anything else related to the stock market.